You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
Lyrica
Pfizer, Inc., announced on September 21, 2005, that Lyrica (pregabalin) capsules are now available for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN) and adjunctive treatment of partial onset seizures in adults with epilepsy.
“Until now, we’ve had limited options to treat patients with these types of neuropathic pain,” says Edgar Ross, MD, director of the Pain Management Center at Brigham and Women’s Hospital in Boston. “I have seen the benefits of Lyrica in providing rapid and sustained pain relief among my patients in the clinical trials.”
According to Pfizer, Lyrica is the first treatment approved by the U.S. Food and Drug Administration to treat two distinct forms of neuropathic pain and is the first new antiepileptic drug introduced in five years.
Lyrica is available in pharmacies nationwide. For more information, log on to www.lyrica.com.
Source: Pfizer, Inc.
What Is Neuropathic Pain?
Neuropathic pain is caused by nerve damage that can result from underlying conditions, such as diabetes or shingles. Nearly half of the 18 million Americans with diabetes will develop some form of diabetic neuropathy over the course of their disease and will suffer from neuropathic pain.
Source: Pfizer, Inc.
Side Effects of Lyrica
The most common side effects of Lyrica are dizziness, sleepiness, dry mouth, swelling of hands and feet, blurred vision, weight gain and trouble concentrating. Patients with a history of drug or alcohol abuse may have a higher chance of misuse or abuse of Lyrica.
Source: Pfizer, Inc.
Categories: Diabetes, Diabetes, Food, Nerve Care (Neuropathy), Type 1 Issues
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...